Skip to main content
. Author manuscript; available in PMC: 2010 Feb 19.
Published in final edited form as: Ann Intern Med. 2009 Apr 7;150(7):437–446. doi: 10.7326/0003-4819-150-7-200904070-00003

Table 4.

Frequency of Patient/Physician Smoking Related Discussions by Treatment Cycle Among Recipients of Pharmacotherapy Management (PM), Moderate-Intensity Disease Management (MDM) and High-Intensity Disease Management*

No. / Total seen by physician (%)
Months PM MDM HDM
0–6 97/171 (56.7) 84/164 (51.2) 94/158 (59.5)
6–12 75/155 (48.4) 70/148 (47.3) 63/137 (46.0)
12–18 67/156 (43.0) 55/124 (44.4) 54/130 (41.5)
18–24 61/141 (43.3) 51/136 (37.5) 47/125 (37.6)
*

GLMM for having a patient-physician smoking related discussion did not provide evidence for a treatment-by-time interaction (df=6, p=0.87). Estimated marginal odds ratios from the GLMM were 1.03 (95% CI 0.75 to 1.41) for HDM vs. MDM, and 0.92 (95% CI 0.70 to 1.19) for HDM and MDM vs. PM.